ConductScience.org, home

Paper36979345

Diffuse Myocardial Fibrosis on Cardiac Magnetic Resonance Imaging Is Related to Galectin-3 and Predicts Outcome in Heart Failure.

Screever EM and 8 others. Biomolecules, 2023. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Diffuse Myocardial Fibrosis on Cardiac Magnetic Resonance Imaging Is Related to Galectin-3 and Predicts Outcome in Heart Failure. Papers, record 36979345. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36979345

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Diffuse Myocardial Fibrosis on Cardiac Magnetic Resonance Imaging Is Related to Galectin-3 and Predicts Outcome in Heart Failure.
PubMed
Journal
Biomolecules
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
2.23
iCite
Revised in PubMed
2026-01-27
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Screever EMElles M
2Gorter TMThomas M
3Willems TPTineke P
4Aboumsallem JPJoseph Pierrehttps://orcid.org/0000-0001-8186-6620
5Suthahar NNavin
6Mahmoud BBelend
7van Veldhuisen DJDirk J
8de Boer RARudolf Ahttps://orcid.org/0000-0002-4775-9140
9Meijers WCWouter C

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CardiomyopathiesMajor topic
Heart FailureMajor topic
Animals
Mice
Biomarkers
Cicatrix
Contrast Media
Fibrosis
Gadolinium
Galectin 3
Magnetic Resonance Imaging
Humans
Blood Proteins
Galectins

Source PubMed

Download CSV of topics

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129459363Heart Failure Stimulates Tumor Growth by Circulating Factors.Circulation2018https://conductscience.org/library/papers/29459363PubMed
235076018Personalized computational heart models with T1-mapped fibrotic remodeling predict sudden death risk in patients with hypertrophic cardiomyopathy.Elife2022https://conductscience.org/library/papers/35076018PubMed
335147665Myocardial fibrosis by T1 mapping magnetic resonance imaging predicts incident cardiovascular events and all-cause mortality: the Multi-Ethnic Study of Atherosclerosis.Eur Heart J Cardiovasc Imaging2022https://conductscience.org/library/papers/35147665PubMed
417112987Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy.J Am Coll Cardiol2006https://conductscience.org/library/papers/17112987PubMed
510471456The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.N Engl J Med1999https://conductscience.org/library/papers/10471456PubMed
621242479Deletion of cardiomyocyte mineralocorticoid receptor ameliorates adverse remodeling after myocardial infarction.Circulation2011https://conductscience.org/library/papers/21242479PubMed
726762873T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure.JACC Cardiovasc Imaging2016https://conductscience.org/library/papers/26762873PubMed
827084804Serial galectin-3 and future cardiovascular disease in the general population.Heart2016https://conductscience.org/library/papers/27084804PubMed
916549783Galectin-3 regulates myofibroblast activation and hepatic fibrosis.Proc Natl Acad Sci U S A2006https://conductscience.org/library/papers/16549783PubMed
1034385704Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial.Nat Med2021https://conductscience.org/library/papers/34385704PubMed
1129447739Native T1 and ECV of Noninfarcted Myocardium and Outcome in Patients With Coronary Artery Disease.J Am Coll Cardiol2018https://conductscience.org/library/papers/29447739PubMed
1215236377Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart.Magn Reson Med2004https://conductscience.org/library/papers/15236377PubMed
1326466857Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH.Eur J Heart Fail2015https://conductscience.org/library/papers/26466857PubMed
1427461364Galectin-3, Cardiac Function, and Fibrosis.Am J Pathol2016https://conductscience.org/library/papers/27461364PubMed
1535511857Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies.Eur Heart J2022https://conductscience.org/library/papers/35511857PubMed
1625637629Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin.Circulation2015https://conductscience.org/library/papers/25637629PubMed
1735976430Comorbidities complicating heart failure: changes over the last 15 years.Clin Res Cardiol2023https://conductscience.org/library/papers/35976430PubMed
1824890535Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials.Am Heart J2014https://conductscience.org/library/papers/24890535PubMed
1934085774Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction.ESC Heart Fail2021https://conductscience.org/library/papers/34085774PubMed
2019850699Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.Circ Heart Fail2010https://conductscience.org/library/papers/19850699PubMed

See all 31 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42985515Review of Galectin-3 and the Collagen Marker PIIINP in Myocardial Fibrosis in Dilated Cardiomyopathy: Predictive Value for Major Adverse Cardiovascular Events.Rev Cardiovasc Med2026https://conductscience.org/library/papers/42985515PubMed
42774454Recent advances in biomarkers for cardiac fibrosis.Front Cardiovasc Med2026https://conductscience.org/library/papers/42774454PubMed
42653479The Clinical Value of NT-proBNP, sST2, and Galectin-3 in the Management of Heart Failure: From Diagnosis to Dynamic Monitoring: A Narrative Review.Int J Mol Sci2026https://conductscience.org/library/papers/42653479PubMed
42299347Myocardial fibrosis and viability: the role of imaging and biomarkers in patients with chronic total occlusion on coronary angiography.Biochem Med (Zagreb)2026https://conductscience.org/library/papers/42299347PubMed
42194704Myocardial Fibrosis in Cardiovascular Disease: An Integrative Biomarker-Imaging Framework Linking Molecular Mechanisms to Structural Phenotypes.J Clin Med2026https://conductscience.org/library/papers/42194704PubMed
41784746Silent Myocardial Infarction Revisited: Immuno-metabolic Mechanisms, Multimodal Biomarkers, and Translational Diagnostics.J Cardiovasc Transl Res2026https://conductscience.org/library/papers/41784746PubMed
40958744Early diagnostic value of novel biomarkers for breast cancer therapy-related cardiac dysfunction.ESC Heart Fail2025https://conductscience.org/library/papers/40958744PubMed
40908522Therapeutic Targets for Myocardial Fibrosis: A Comprehensive Review of Current and Emerging Approaches.Cardiovasc Hematol Disord Drug Targets2026https://conductscience.org/library/papers/40908522PubMed
40747108Tracing the Rise of Galectin-3: A Global Bibliometric Insight Into Its Role in Heart Failure.Int J Vasc Med2025https://conductscience.org/library/papers/40747108PubMed
40399739Cardiac magnetic resonance and genetics in pediatric heart failure patients with nonischemia: prognostic implications.World J Pediatr2025https://conductscience.org/library/papers/40399739PubMed
39155333Association of fibrotic markers with diastolic function after STEMI.Sci Rep2024https://conductscience.org/library/papers/39155333PubMed
38736671Efficacy and Safety of Kuoxin Formula in the Treatment of Dilated Cardiomyopathy-Related Heart Failure: Study Protocol of a Randomized, Double-Blind, Placebo-Controlled, Multi-Center Clinical Trial.Int J Gen Med2024https://conductscience.org/library/papers/38736671PubMed
37767953Evaluation of right ventricular diastolic function, systolic function, and circulating galectin-3 concentrations in dogs with pulmonary stenosis.J Vet Intern Med2023https://conductscience.org/library/papers/37767953PubMed
37685918The Role of Galectin-3 in Heart Failure-The Diagnostic, Prognostic and Therapeutic Potential-Where Do We Stand?Int J Mol Sci2023https://conductscience.org/library/papers/37685918PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CRP1401PubTator's text mininghttps://conductscience.org/library/genes/1401NCBI Gene
GDF159518PubTator's text mininghttps://conductscience.org/library/genes/9518NCBI Gene
LGALS33958PubTator's text mininghttps://conductscience.org/library/genes/3958NCBI Gene
ST26761PubTator's text mininghttps://conductscience.org/library/genes/6761NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36979345

GET https://conductscience.org/api/papers/v1/36979345/references?page=2